Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (209K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (26)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Chernokalskaya, E.
Right arrow Articles by Schoenberg, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chernokalskaya, E.
Right arrow Articles by Schoenberg, D. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1997 Oxford University Press 735-742

Footnote

Cleavage properties of an estrogen-regulated polysomal ribonuclease involved in the destabilization of albumin mRNA

Cleavage properties of an estrogen-regulated polysomal ribonuclease involved in the destabilization of albumin mRNA Elena Chernokalskaya , Raquel Dompenciel 1,+ and Daniel R. Schoenberg*

Department of Pharmacology, The Ohio State University College of Medicine, 333 West 10th Avenue, Columbus , OH 43210-1239, USA and 1 Department of Pharmacology, Uniformed Services University of the Health Sciences, Bethesda , MD 20814-4799, USA

Received November 12, 1996; Revised and Accepted December 27, 1996

ABSTRACT

Previous work from this laboratory [Dompenciel,R.E., Garnepudi,V.R. and Schoenberg,D.R. (1995) J. Biol. Chem. 270, 6108-6118] described the purification and properties of an estrogen-regulated endonuclease isolated from Xenopus liver polysomes that is involved in the destabilization of albumin mRNA. The present study mapped cleavages made by this enzyme onto the secondary structure of the portion of albumin mRNA bearing the major cleavage sites. The predominant cleavages occur in the overlapping APyrUGA sequence AUUGACUGA present in a single-stranded loop region, and in AUUGA located within a bulged AU-rich stem. A structural mutation which converted the major loop cleavage site to a hairpin bearing one APyrUGA element eliminated cleavage at the intact site. This confirms that the polysomal RNase is specific for single-stranded RNA. Additional point mutations in the major loop characterized the nucleoside sequence requirements for cleavage. Finally, snake venom exonuclease was used to demonstrate the polysomal RNase generates products with a 3 ' hydroxyl. Binding of an estrogen-induced protein to a portion of the 3 ' UTR of vitellogenin mRNA may be involved in its stabilization by estrogen [Dodson,R.E. and Shapiro,D.J. (1994) Mol. Cell. Biol. 14, 3130-3138]. The core binding site for this protein bears the sequence APyrUGA, suggesting that stabilization may be accomplished by occlusion of a cleavage site for the polysomal RNase.

INTRODUCTION

The digestion of a given mRNA in vivo by a ribonuclease may be thought of as either an initial rate-limiting step in the process of its turnover, or as the ultimate endpoint of a series of molecular interactions that culminate in the degradation of the molecule. The nucleolytic processes that have been implicated to date in the turnover of eukaryotic mRNAs include almost every conceivable mechanism (reviewed in 1 ). 3'-5' Exonucleases appear to be important in the turnover of a wide variety of polyadenylated mRNAs and the non-polyadenylated histone mRNA ( 2 ). In yeast, the process of mRNA destabilization begins with the loss of the 3' poly(A) tail, probably by the action of poly(A) nuclease (or PAN; 3 , 4 ). Subsequent to poly(A) shortening, yeast mRNAs undergo decapping by a pyrophosphatase followed by 5'-3' degradation by the exonuclease encoded by the XRN1 gene ( 5 ). Parker and co-workers ( 6 ) have found that, at least in yeast, nonsense-mediated decay proceeds through decapping and 5'-3' degradation without prior deadenylation, indicating that these are separable processes.

While neither PAN nor a decapping pyrophosphatase have been definitively identified in higher eukaryotes, a number of unstable mammalian mRNAs which have AU-rich elements in their 3' UTR (e.g. cytokines, oncogenes and transcription factors) also undergo deadenylation prior to decay (see review by Ross, 7 ). While there is no in vivo evidence for decapping and 5'-3' degradation as seen in yeast, a 5' exonuclease has been identified that is capable of removing the cap and degrading the body of the mRNA ( 8 ). Endonucleolytic cleavage is an important, and likely rate-limiting, step in the decay of a number of vertebrate mRNAs. Examples of mRNAs that appear to be degraded through endonucleolytic processes include avian apo-very low density lipoprotein II ( 9 ), insulin-like growth factor II (IGF II) ( 10 ), maternal homeobox-containing mRNAs ( 11 , 12 ), the cytokine gro [alpha] ( 13 ) and transferrin receptor ( 14 ). In the case of the Xenopus maternal homeobox mRNAs, a ribonuclease activity was identified in oocyte extracts that acts like an RNA restriction endonuclease, cleaving only at a specific sequence element present within the 3' UTR ( 12 ). Structural features do not appear to be important for the specificity of this enzyme, since a 19 base sequence is sufficient to impart sensitivity to endonucleolytic cleavage to a heterologous mRNA. In contrast, IGF II mRNA is highly structured, and it is likely that structural constraints play a major role in targeting endonucleolytic cleavage to a specific site in the 3' UTR ( 10 ).

The highly-efficient synthesis of the yolk protein precursor vitellogenin in response to estrogen stimulation of Xenopus liver results from both transcriptional and post-transcriptional processes. Estrogen, acting through its nuclear receptor, causes the transcriptional induction of the four vitellogenin genes ( 15 , 16 ). In addition, vitellogenin mRNA is also stabilized by estrogen through an estrogen receptor-dependent process ( 17 ). While these pathways lead to significant accumulation of vitellogenin mRNA, one might predict that the very short (13 nucleotide) 5' UTR present on this mRNA would make it a poor competitor for translation initiation in the presence of high levels of serum protein-coding mRNAs normally found in liver polysomes. However, such competition does not occur in vivo because estrogen also causes the coordinate destabilization of the mRNAs encoding the major serum proteins, including albumin, transferrin and the fibrinogens ( 18 - 20 ). The process of coordinate mRNA destabilization is restricted to mRNAs for serum proteins; ferritin, poly(A)-binding protein and actin mRNA levels are unaffected by estrogen.

In earlier studies we identified an estrogen-induced ribonuclease activity on Xenopus liver polysomes whose properties suggested it may be involved in the destabilization of the serum protein-coding mRNAs ( 21 , 22 ). A hallmark of this activity is its selectivity; whereas it degrades albumin mRNA present either free in solution, as mRNP or on polysomes, it does not degrade ferritin mRNA ( 22 ). Furthermore, this activity is a component of neither ribosomal subunit, but requires both subunits be together in an 80S complex for its binding to polysomes ( 21 ). The purified RNase consists of two isoforms of molecular mass 62 000 and 64 000 ( 23 ), which most likely result from the duplication of the Xenopus genome. The purified RNase has many of the same properties reported earlier for the activity present in crude polysome extracts ( 22 ). These include specificity for albumin versus ferritin mRNA, resistance to inhibition by EDTA or placental ribonuclease inhibitor, and a lack of dependence on divalent cations for activity. Two dimensional gel electrophoresis showed the RNase purified from liver of estrogen-treated Xenopus consists of three isoforms with isoelectric points of 9.6, 9.7 and 9.8. These are likely the result of post-translational modification. While the significance of this modification is unknown at present, we suspect these changes are involved in either the activation of the RNase by estrogen or its ability to target to polysomes.

This putative messenger RNase was purified based on its ability to generate a doublet cleavage product of ~194 nucleotides (nt) using as substrate a uniformly labeled 500 nt transcript from the 5' end of albumin mRNA. The cleavage that generated this doublet was mapped to the sequence AUUGACUGA, which can be thought of as two overlapping copies of the pentamer APyrUGA. This element is present multiple copies in mRNAs that are destabilized in response to estrogen (14 in albumin, nine in transferrin and seven in [gamma]-fibrinogen), but it is absent in ferritin mRNA. Furthermore, this sequence is not cleaved when the radiolabeled substrate transcript is converted to a double-stranded RNA by hybridization to an excess of antisense transcript. These results suggest that the structural context of the APyrUGA element may be important for cleavage by the polysomal RNase. The purpose of the present study was to solve the secondary structure surrounding the major cleavage site on albumin mRNA, and use this information to determine the role both structure and primary sequence play in cleavage by the polysomal RNase. We show here that the polysomal RNase preferentially cleaves at APyrUGA located in a single-stranded region of a stem-loop structure, but can also cleave at adjacent sites. Furthermore, collapsing this loop to a hairpin bearing a single APyrUGA element in double-stranded RNA blocked cleavage, confirming the importance of substrate structure. In addition, we demonstrate that cleavage generates products with a free 3' hydroxyl which may be susceptible to exonucleolytic degradation in vivo .

MATERIALS AND METHODS

The purification of the polysomal RNase, preparation of plasmids, assay for ribonuclease activity, preparation of transcripts and gel analyses were performed as described by Dompenciel et al . ( 23 ). The handling of experimental animals and preparation of total RNA were performed as described by Schoenberg et al . ( 20 ). The experiments reported herein were conducted according to the principles set forth in the Guide for the Care and Use of Laboratory Animals, Institute of Animal Resources, National Research Council, Department of Health and Human Services Pub. No. (NIH) 78-23.

Secondary structure analysis

RNase T1 and A digestion of total liver RNA from male Xenopus was done under non-denaturing conditions in buffer containing 20 mM Tris-HCl, pH 8.0, 5 mM MgCl 2 and 50 mM KCl. RNase U2 digestion was performed in buffer containing 15 mM sodium citrate, pH 3.6, 50 mM MgCl 2 and 50 mM KCl. Prior to enzymatic digestion 10 [mu]g samples of total liver RNA were heated in the above buffers at 50oC for 5 min and slowly cooled to 25oC to insure proper folding. Digestion was performed with 10 U/[mu]l RNase T1, 1 U/[mu]l RNase U2 and 0.1 ng/[mu]l RNase A at 25oC. Equal portions were removed after 5, 10 and 15 min of digestion. The reactions were stopped by addition of 9 vol 0.3 M sodium acetate, pH 5.0, 10 mM EDTA and extraction with an equal volume of phenol:HCCl 3 :isoamyl alcohol (25:24:1). RNA was recovered by ethanol precipitation and analyzed by primer extension.

Primer extension

Primer extension was performed as described previously ( 24 ). Ten [mu]g total liver RNA or 20 ng in vitro transcript (plus 10 [mu]g yeast tRNA) were ethanol precipitated with 1-2 * 10 5 d.p.m. of 5' end-labeled primer. The primer used for secondary structure analysis in Figure 1 consisted of the sequence CACTCAGGAGTTTTGTCATTAA (DAN25), which is complementary to nucleotides 280-301 of the 74 kDa albumin mRNA. The precipitated RNA and primer were dissolved in 10 [mu]l annealing buffer (50 mM Tris-HCl, pH 8.7, 0.54 M KCl, 1 mM EDTA), heated at 65oC for 10 min and slowly cooled to 25oC. To each tube was added a mixture of 0.9 mM dATP, dCTP, dGTP, TTP, 50 mM Tris-HCl, pH 8.3, 13 mM MgCl 2 , 7 mM dithiothreitol and 200 U M-MLV reverse transcriptase to a total volume of 40 [mu]l. The reaction mixture was incubated for 1.5 h at 42oC and stopped by the addition of 260 [mu]l 0.3 M sodium acetate, 10 mM Tris-HCl, pH 8.0, 1 mM EDTA followed by the addition of 600 [mu]l cold ethanol. The final pellets were dissolved in 6 [mu]l formamide loading buffer and electrophoresed on a 6% acrylamide/urea gel. The position of primer extension stops and nuclease cleavage sites was determined relative to a sequencing ladder prepared from the cloned cDNA and the same primer.

Construction and analysis of sequence and structural mutations in the major cleavage site

Site-directed mutagenesis was performed using the pBluescript plasmid containing the 5' 470 bp of albumin cDNA that bears the site which yields the characteristic doublet cleavage product following digestion with the mRNase. Mutagenesis was done by the method of Jones and Howard ( 25 ). The following mutations were prepared. Lower case letters represent the change from the wild-type sequence. The HP160 mutation collapsed the loop containing the major cleavage sites. The albumin plasmid pXa470 was amplified with pair EC4 (GTATACACCGCtcaGACTGAGCGGA, corresponding to position 147-171) plus EC6 (ATCAGCAATATGCTTGTGATGGT, corresponding to position 146-124) and pair EC5 (TCCGCTCAGTCtgaGCGGTGTATAC, corresponding to position 171-147) and EC7 (CCTTCAAAGGACTTACATTGGCT, corresponding to position 171-193). PCR products were purified on agarose gels, mixed, annealed and used to transform competent Escherichia coli . Positive clones were selected by colony hybridization to 5'-labeled primer EC5. The U164A mutation was prepared as above with primers EC8 (GTATACACCGCATTGACaGAGCGGA, corresponding to position 147-171) plus EC6, and EC9 (TCCGCTCtGTCAATGCGGTGTATAC, corresponding to position 171-147) plus EC7. Selection was done by hybridization to radiolabeled EC8. The G165C mutation was prepared with primers EC10 (GTATACACCGCATTGACTcAGCGGA) plus EC6, and EC11 (TCCGCTgAGTCAATGCGGTGTATAC) plus EC7. Selection was done by hybridization to radiolabeled primer EC10. The U159A mutation was prepared with primers EC16 (GTATACACCGCAaTGACTGAGCGGA) plus EC6, and EC17 (TCCGCTTCAGTCAtTGCGGTGTATAC) plus EC7. Selection was done by hybridization to radiolabeled primer EC16. The T160A mutation was prepared with primers EC14 (GTATACACCGCATaGACTGAGCGGA) plus EC6, and primers EC15 (TCCGCTCAGTCtATGCGGTGTATAC) plus EC7. Selection was done by hybridization to radiolabeled primer EC14. The A162U mutation was prepared with primers EC18 (GTATACACCGCATTGtCTGAGCGGA) plus EC6, and EC19 (TCCGCTCAGaCAATGCGGTGTATAC) plus EC7. Selection was done by hybridization to radiolabeled primer EC18. All mutations were sequenced to insure that no additional changes were introduced during PCR. Furthermore, the structure of each of the RNAs prepared from these mutations was confirmed by digestion with RNase T1. The cleavage of wild-type and mutated albumin RNAs by the mRNase was assayed using RNAs that were end-labeled by in vitro transcription in a mixture containing [[gamma]- 32 P]GTP. A sequencing ladder was run as a size standard with each reaction.

Phosphorylation status of cleavage products

Prior to digestion, 5' end-labeled transcripts were heated in buffer for each nuclease at 50oC for 5 min, and cooled slowly to 25oC to insure proper folding. RNase T 1 digestion buffer contained 2.5 mM Tris-HCl pH 7.2, 2.5 mM MgCl 2 and 25 mM KCl. S1 nuclease buffer contained 30 mM sodium acetate pH 4.6, 50 mM NaCl, 10 mM zinc acetate and 5% glycerol. Buffer for the polysomal RNase contained 40 mM Tris-HCl pH 7.2, 2 mM dithiothreitol and 5 mM MgCl 2 . All reactions also contained 0.25 [mu]g/[mu]l yeast tRNA. Digestions were performed at 25oC in a 20 [mu]l volume for 10 min for RNase T 1 and S1 nuclease, and 30 min for the polysomal nuclease. The amounts of nuclease used were 0.05 U/[mu]l RNase T 1 , 0.05 U/[mu]l S1 nuclease and 10 ng/[mu]l of the polysomal RNase. The reactions were stopped by addition of 15 [mu]l 7.5 M ammonium acetate plus 115 [mu]l H 2 O, followed by extraction with phenol/HCCl 3 /isoamyl alcohol (25:24:1) and ethanol precipitation. The resultant pellets were dissolved in 15 [mu]l phosphodiesterase buffer, which consisted of 100 mM Tris-HCl, pH 8.7, 100 mM NaCl and 14 mM MgCl 2 . Three [mu]l portions were mixed with 1 [mu]l snake venom phosphodiesterase (Boehringer) containing 3 * 10 -2 U/[mu]l. Reactions were incubated for 10 min at 25oC and were stopped by addition of 4 [mu]l formamide loading buffer followed by heating for 5 min at 70oC. Digestion products were analyzed by electrophoresis on a 6% urea/acrylamide gel.

RESULTS

Structure of the major cleavage site in the 5 ' end of albumin mRNA

We previously reported that the cleavage which generates the doublet at position 194 (relative to the 5' end of a T3 RNA polymerase-generated transcript of albumin mRNA) mapped to the sequence AUUGACUGA. This sequence, which can be thought of as two overlapping copies of the sequence APyrUGA, lies between nucleotides 158-166 on albumin mRNA, the difference in numbering resulting from the presence of polylinker sequence on the in vitro transcript. The numbering used here corresponds to the sequence of albumin mRNA, with position 1 being the cap site.


Figure 1 . Secondary structure determination of the major cleavage site in albumin mRNA. Ten [mu]g total liver RNA from control Xenopus was digested for increasing times with RNase T1 (lanes 2-4), U2 (lanes 9-11) or A (12-14). The products were analyzed by primer extension using an end-labeled primer to position 280-301. The position of cleavage sites was determined relative to a DNA sequencing ladder prepared with the same primer (lanes 5-8). The control of undigested RNA is shown in lane 1. With the positions of single-stranded bases fixed the sequence was processed by a suboptimal folding program (MFOLD in the Wisconsin Genetics Computer Group Suite). The resulting secondary structure map is shown below the autoradiogram, with the cleavage sites indicated for each RNase.

To characterize further the cleavages that generate the characteristic doublet product from the 5' portion of albumin mRNA we first determined secondary structure of the region surrounding these sites. In order to avoid the possibility of structural artifacts caused by plasmid sequences present in T3 transcript this structure was determined by digestion with structure-specific RNases and primer extension using albumin mRNA present in total liver RNA extracted from control (non-estrogen treated) male Xenopus . In the experiment shown in Figure 1 , liver RNA was digested with RNases T1, U2 and A for 5, 10 and 15 min under non-denaturing conditions in buffer containing 5 mM MgCl 2 and 50 mM NaCl. The positions of nucleotides fixed in single-stranded regions of the RNA were used to calculate the secondary structure by a suboptimal folding algorithm (MFOLD in the Wisconsin GCG package). The resulting map of the secondary structure is shown on the bottom of Figure 1 . This portion of albumin mRNA is highly structured, with the overlapping AUUGACUGA cleavage site located in a single-stranded loop in nucleotides 158-166. This result confirms our original observation that the polysomal RNase is a single strand-specific enzyme ( 23 ). It should be noted that the secondary structure this portion of albumin mRNA is the same for RNA isolated from liver and for transcripts prepared in vitro from cloned albumin cDNA (data not shown), thus validating the use of these transcripts in the experiments below to assess the effects of sequence and structural alterations on cleavage by the polysomal RNase.

The polysomal RNase cleaves at multiple sites within the albumin substrate transcript

The 194 nt doublet cleavage product does not accumulate stoichiometrically, even with highly purified enzyme. We suspected that, unlike the homeobox-specific RNase identified in Xenopus oocytes ( 11 , 12 ), the liver polysomal RNase cleaves its substrate RNA at multiple sites, with the major 194 nt product also serving as the substrate for additional cleavages. To test this, reactions were performed with substrate that was labeled on the 5' end by inclusion of [[gamma]- 32 P]GTP in the transcription reaction. The reasoning behind this was that the relative signal intensity of digestion products from end-labeled substrate is independent of length, whereas signal intensity of products from uniformly-labeled substrate is proportional to length. Furthermore, the use of end-labeled substrate allows an approximation of the relative activity at a particular site independent of product size. Digestion of wild-type albumin transcript (Fig. 2 , lane 3) yields the characteristic doublet products, plus three additional cleavages within the mapped structure domain. These are labeled 1-5 on the figure and indicated on the adjacent structure diagram. Sites 1 and 2 (black arrows) correspond to the cleavages at 159 and 163 which generate the characteristic doublet product. Several weaker cleavage sites (3 and 4) are also seen, plus an unexpected strong cleavage site was found further upstream at position 5. The identification of additional cleavages on the substrate transcript is in agreement with the observed absence of stoichiometry in accumulation of the doublet cleavage product. With the exception of site 5, all of the additional cleavage sites fall within single stranded regions. Site 5 contains the core sequence AUUGA in an AU-rich stem adjacent to a bulge, so it is conceivable that localized unpairing of this structure might make the sequence accessible for cleavage. It is noteworthy that the strongest cleavages all contain the sequence APyrUGA, suggesting that this sequence is a preferred site for the RNase. Densitometry was used to determine the relative signal intensities of the five bands resulting from cleavage of wild-type transcript (lane 3). By arbitrarily setting the signal of the weakest band (site 4) to 1, the strongest signal intensities were seen at site 1 (8.6), site 2 (5.2) and site 5 (3.0), all of which have the APyrUGA pentamer. Stated another way, cleavages at positions 1, 2 and 5 accounted for 43, 27 and 15%, respectively of the total products in this portion of albumin mRNA. Since cleavages at sites 3-5 will each reduce the amount of the doublet product seen with uniformly-labeled transcript, we conclude that these additional cleavages are responsible for the lack of stoichiometry observed in our assays using the purified RNase.


Figure 2 . Cleavages within wild-type and mutant albumin mRNAs. 5' end-labeled transcripts were prepared that correspond to the 5' 470 nt of albumin mRNA. These were incubated without (even numbered lanes) or with (odd numbered lanes) polysomal RNase as described previously (23) and analyzed on a 6% acrylamide/urea gel. Lanes 2 and 3 contain wild-type transcript. Lanes 4 and 5 contain a mutant transcript in which the central loop was collapsed into a hairpin structure (hp160). Lanes 6 and 7 contain a transcript bearing a U to A mutation at position 164. Lanes 8 and 9 contain a transcript bearing a G to C mutation at position 165. A DNA sequencing ladder in lane 1 is included as a size standard. The sequence and structure of these mutations are shown on the right side of the figure. The individual cleavage products are numbered on the right side of the autoradiogram and are shown graphically on the secondary structure model for wild-type RNA, with the black arrows indicating the position of the cleavage sites which generate the characteristic doublet cleavage product from uniformly labeled transcript. The structures of all mutations were analyzed to insure that they either had no effect on the secondary structure of the RNA (U164A and G165C) or altered the secondary structure (hp160).

The next experiments sought to define further the nature of the major loop cleavage site. Based on the earlier observation that double-stranded RNA was not cleaved ( 23 ), a mutant substrate transcript (hp160) was prepared in which the first three nucleotides of the 158-166 loop were changed to produce a hairpin structure. The structural change produced by this mutation was confirmed by nuclease digestion as in Figure 1 . While the hp160 mutation changed the sequence at site 3 (position 159), it left intact the primary sequence of site 2 (see diagram on the right side of Fig. 2 ). The data in lane 5 show that this change in secondary structure abolished all cleavage in this portion of the molecule without affecting other cleavages. This result confirms the earlier finding that the polysomal RNase is specific for single-stranded regions of RNA.

Sequence context for cleavage within the 158-166 loop

A series of point mutations were prepared in various positions within the 158-166 loop to characterize the sequences involved in cleavage of this region by the polysomal RNase. We could not perform saturation mutagenesis because many of these changes altered the secondary structure of the substrate. Rather, only those mutations that did not alter the secondary structure of the RNA were selected, a result which was confirmed by enzymatic secondary structure analysis as in Figure 1 (data not shown). Lanes 6-9 in Figure 2 shown the effect of two single base mutations made in the 3' portion of the loop which converted U164 to A and G165 to C. Both mutations abolished cleavage at site 2 (lanes 7 and 9), but had no effect on cleavage at site 3 on the opposite side of the loop or any of the other cleavages.

The effect of mutations at the top and in the 5' half of the 158-166 loop are shown in Figure 3 . The A162U mutation at the top of the loop had no effect on cleavage at any site (compare lanes 2 and 4). Similarly, converting U159 to A had no effect (lane 6). However, mutating the second pyrimidine (U160) in this sequence to A abolished cleavage at site 3 with no effect on other sites within the molecule. We conclude from the data in Figures 2 and 3 that, while the APyrUGA sequence element is a major site for cleavage by the mRNase, it is by no means the only site. Furthermore, cleavage at the APyrUGA element requires that this sequence be in a single-stranded context, and the most critical residues affecting cleavage are the adjacent U and G nucleotides.

RNase cleavage generates products with free 3 ' hydroxyls


Figure 3 . Effect of mutations in the 5' portion of the major cleavage site. The mutations shown on the bottom right portion of the figure were introduced into the 5' portion of the major loop cleavage site. Each mutant RNA was examined by digestion with purified RNase as described in the legend to Figure 2.

In an earlier report we noted cleavage by the polysomal RNase generated products with free 5' hydroxyls, and by inference, 3' phosphates. This interpretation came from forward labeling experiments performed on reaction products incubated with T4 polynucleotide kinase and [[gamma]- 32 P]ATP. The drawback to this approach is that a positive result could be obtained artifactually if a small portion of the products lost a 5' phosphate after cleavage and prior to labeling. In bacteria, a major pathway of mRNA degradation involves endonucleolytic cleavage by RNase E followed by 3'-5' exonucleolytic degradation by polynucleotide phosphorylase [reviewed in ( 26 )]. A similar mechanism is likely to function in vertebrates. Since RNAs with 3' phosphate groups are poor substrates for 3'-5' exonucleases, we reasoned that an endonuclease involved in vertebrate mRNA turnover should also generate products with 3' hydroxyls. Hence, the nature of the 3' end of the RNase cleavage products was re-examined using digestion with snake venom exonuclease to differentiate between products with 3' hydroxyls versus those bearing 3' phosphates. In the experiment shown in Figure 4 , 5' end-labeled albumin substrate transcript was digested with RNase T1 to generate products with 3' phosphates (lanes 3 and 4), S1 nuclease to generate products with 3' hydroxyls (lanes 5 and 6), and the polysomal RNase (lanes 7 and 8). The products of these reactions were either loaded directly onto the gel (lanes 3, 5 and 7) or treated with snake venom exonuclease prior to electrophoresis (lanes 4, 6 and 8). Snake venom exonuclease had no effect on the amount or size of the individual T 1 cleavage fragments (lane 4). However, the substrate transcript itself (which has a 3' hydroxyl) was degraded (lane 4). S1 nuclease cleavage products were all susceptible to degradation by snake venom exonuclease, as evidence by smearing of the product bands and shift to faster mobility on the gel (lane 6). A similar result is seen in lane 8 for products generated from cleavage by the polysomal RNase. The preparation of RNase used here had lost activity during storage, hence the lowered amount of substrate cleavage. However, the 194 nt doublet cleavage product in lane 7 (arrow) along with other degradation fragments show definite smearing into faster-migrating species, indicative of 3'-5' degradation by the exonuclease. Thus, the polysomal RNase cleaves on the 3' side of the phosphodiester bond to yield products with free 3' hydroxyl groups.


Figure 4 . The polysomal RNase generates products with 3' hydroxyls. 5' end-labeled albumin transcript was digested with RNase T 1 (lanes 3 and 4), S1 nuclease (lanes 5 and 6) or the polysomal RNase (lanes 7 and 8). The products of these reactions were incubated for 10 min with 3 * 10 -2 U snake venom exon exonuclease (lanes 4, 6 and 8), and electrophoresed on a 6% polyacrylamide/urea gel . The arrow indicates the position of the characteristic 194 nt doublet cleavage of the polysomal RNase. Lane 1 contains a size marker and lane 2 is the starting substrate transcript.


Figure 5 . Comparison between sites of estrogen-regulated protein interactions on albumin and vitellogenin mRNA. The secondary structure map for the major cleavage site on albumin mRNA is shown on the left portion of the figure with the APyrUGA elements highlighted by a solid black line. The bottom portion of the figure shows the sequence of portions of the 3' UTR of vitellogenin B1 and B2 mRNA which bear the core sequence elements believed to be involved in the binding of an estrogen-induced protein which stabilizes this mRNA (33).

DISCUSSION

A number of important insights were gained by studying sequence and structural elements involved in cleavage by the polysomal RNase. As noted above, the cleavage sites responsible for generating the characteristic doublet product from albumin mRNA (sites 1 and 2) lie in a single-stranded loop which bears the sequence AUUGACUGA. We previously noted that this can be viewed as an overlapping repeat of the sequence APyrUGA ( 23 ). Another cleavage site (site 5) also contains the sequence AUUGA in a bulged stem structure that could conceivably become single stranded by localized unpairing. Of the five sites analyzed here, cleavage at these three sites comprise 85% of the products mapped to this region of albumin mRNA. The fact that cleavage occurs at sites other than APyrUGA indicates that the polysomal RNase is sequence selective (as opposed to being sequence specific). This contrasts with the oocyte RNase that cleaves only a specific sequence within maternal homeobox mRNAs ( 11 , 12 ).

Data obtained with the hp160 mutation, in which the 158-166 loop was collapsed to a hairpin, demonstrate that the nuclease is selective for single-stranded RNA and cannot cleave even though the APyrUGA element was present. Thus, while this element could occur with relatively high frequency in cellular mRNA, it must be in a single-stranded portion of the molecule to be accessible to the polysomal RNase. The sequence APyrUGA is present 14 times in albumin, nine times in transferrin and seven times in [gamma]-fibrinogen mRNA, all of which are destabilized following estrogen ( 18 ). Ferritin mRNA, which is not degraded by the polysomal nuclease ( 18 , 23 ), lacks the sequence APyrUGA. Cleavage sites 3 and 4 do not contain this pentamer, so it is not clear how they are selected. Both are cleaved to the same degree in the hp160 mutation, so selection at these sites must be independent of cleavage in the loop. The hp160 construct retained APyrUGA at position 5, so it is conceivable that a single site is sufficient for substrate selectivity, with additional cleavages resulting from those sequences adopting a particular secondary or tertiary structure. Alternatively, selectivity may come from the overall secondary or tertiary structure, with APyrUGA serving as a preferred cleavage site when present in a single-stranded portion of the molecule.

A major pathway for mRNA degradation in prokaryotes consists of endonucleolytic cleavage by RNase E in a single-stranded region adjacent to a stable structural element, followed by 3'-5' degradation of the resultant product by polynucleotide phosphorylase (reviewed in 26 ). These two steps in mRNA turnover appear to be coupled, as both enzymes are found in a single macromolecular complex ( 27 - 30 ). Since the prokaryotic and eukaryotic 3'-5' exonucleases that have been identified require a substrate with a free 3' hydroxyl for maximal activity, one would anticipate that vertebrate endonucleases involved in mRNA turnover would generate products like those resulting from RNase E cleavage. Results in Figure 4 show that cleavage by the polysomal RNase generates products with free 3' hydroxyls. This contrasts with our earlier finding that cleavage products had 5' ends that could be phosphorylated by T4 kinase. The latter finding most likely resulted from dephosphorylation of a sub-population of RNase cleavage products. Subsequent incubation with kinase and [[gamma]- 32 P]ATP would give the erroneous impression that the entire population became phosphorylated. Since the starting substrate was labeled in Figure 4 , the approach used here more accurately reflects the properties of the entire population of degradation fragments.

In addition to its action to destabilize albumin and other mRNAs encoding serum proteins, estrogen causes the transcriptional induction and stabilization of the mRNA for the yolk protein precursor vitellogenin ( 31 , 32 ). Recently Dodson and Shapiro ( 33 ) described an estrogen-regulated protein which selectively binds to a region in the 3' UTR of vitellogenin mRNA and may be involved in the regulation of its stability. The core sequence for this binding contained either one or two copies of the element ACUGAU, depending on whether they examined the B2 or B1 vitellogenin mRNA. This portion of both vitellogenin mRNAs as well as the region of albumin mRNA examined here are shown in Figure 5 . The similarity to polysomal RNase cleavage sites characterized in the present study is striking. Based on this observation, a potential mechanism for the stabilization of vitellogenin mRNA by estrogen might be the induction of a protein that blocks access to this sequence by a messenger RNase. Binder et al . ( 14 ) have proposed a similar mechanism for the stabilization of transferrin receptor mRNA, in which an iron-regulated protein (IRP1) occludes an endonuclease cleavage site by binding to iron response elements in the 3' UTR. If this turns out to be the case for the stabilization of vitellogenin, it will be important to determine why the same protein does not prevent the destabilization of albumin and other serum protein-coding mRNAs bearing the APyrUGA element. The answers to these questions may provide important insights into the molecular interactions involved in the differential regulation of mRNA stability.

ACKNOWLEDGEMENTS

We wish to thank Murray Deutscher for his suggestion about using snake venom exonuclease for mapping the 3' ends of the cleavage products. This work was supported by Public Health Service Grant GM38277 from the National Institutes of Health. R.E.D. was supported in part by a Research Supplement for Underrepresented Minorities from the National Institute of General Medical Sciences and by a Ford Foundation Minority Postdoctoral Fellowship.

REFERENCES

1 Schoenberg,D.R. and Chernokalskaya,E. (1997) In Harford,J. and Morris,D.R. (eds), mRNA Metabolism and Post-transcriptional Gene Regulation. Wiley, New York (in press).

2 Caruccio,N. and Ross,J. (1994) J. Biol. Chem. 269, 31814-31821.

3 Lowell,J.E., Rudner,D.Z. and Sachs,A.B. (1992) Genes Dev. 6, 2088-2099.

4 Boeck,R., Tarun,S.,Jr., Rieger,M., Deardorff,J.A., Mueller-Auer,S. and Sachs,A.B. (1996) J. Biol. Chem. 271, 432-438.

5 Muhlrad,D., Decker,C.J. and Parker,R. (1994) Genes Dev. 8, 855-866.

6 Muhlrad,D. and Parker,R. (1994) Nature, 370, 578-581.

7 Ross,J. (1995) Microbiol. Rev. 59, 423-450.

8 Somoskeoy,S., Rao,M.N. and Slobin,L.I. (1996) Eur. J. Biochem. 237, 171-179.

9 Binder,R., Hwang,S.P., Ratnasabapathy,R. and Williams,D.L. (1989) J. Biol. Chem. 264, 16910-16918.

10 Scheper,W., Meinsma,D., Holthuizen,P.E. and Sussenbach,J.S. (1995) Mol. Cell. Biol. 15, 235-245.

11 Brown,B.D. and Harland,R.M. (1990) Genes Dev. 4, 1925-1935.

12 Brown,B.D., Zipkin,I.D. and Harland,R.M. (1993) Genes Dev. 7, 1620-1631.

13 Stoeckle,M.Y. (1992) Nucleic Acids Res. 20, 1123-1127.

14 Binder,R., Horowitz,J.A., Basilion,J.P., Koeller,D.M., Klausner,R.D. and Harford,J.B. (1994) EMBO J. 13, 1969-1980.

15 Chang,T.C. and Shapiro,D.J. (1990) J. Biol. Chem. 265, 8176-8182.

16 Corthesy,B., Cardinaux,J.-R., Cardinaux,J.-F., Claret,F.X. and Wahli,W. (1989) Mol. Cell. Biol. 9, 5548-5562.

17 Nielsen,D.A. and Shapiro,D.J. (1990) Mol. Endocrinol. 4, 953-957.

18 Pastori,R.L., Moskaitis,J.E., Buzek,S.W. and Schoenberg,D.R. (1991) Mol. Endocrinol. 5, 461-468.

19 Pastori,R.L., Moskaitis,J.E., Smith,L.H. and Schoenberg,D.R. (1990) Biochemistry, 29, 2599-2605.

20 Schoenberg,D.R., Moskaitis,J.E., Smith,J.H.,Jr. and Pastori,R.L. (1989) Mol. Endocrinol. 3, 805-814.

21 Pastori,R.L. and Schoenberg,D.R. (1993) Arch. Biochem. Biophys. 305, 313-319.

22 Pastori,R.L., Moskaitis,J.E. and Schoenberg,D.R. (1991) Biochemistry, 30, 10490-10498.

23 Dompenciel,R.E., Garnepudi,V.R. and Schoenberg,D.R. (1995) J. Biol. Chem. 270, 6108-6118.

24 Shelness,G.S. and Williams,D.L. (1985) J. Biol. Chem. 260, 8637-8646.

25 Jones,D.H. and Howard,B.H. (1990) BioTechniques, 8, 178-183.

26 Alifano,P., Bruni,C.B. and Carlomagno,M.S. (1994) Genetica, 94, 157-172.

27 Carpousis,A.J., Vanhouwe,G., Ehretsmann,C. and Krisch,H.M. (1994) Cell, 76, 889-900.

28 Py,B., Causton,H., Mudd,E.A. and Higgins,C.F. (1994) Mol. Microbiol. 14, 717-729.

29 Miczak,A., Kaberdin,V.R., Wei,C.L. and Lin-Chao,S. (1996) Proc. Natl. Acad. Sci. USA, 93, 3865-3869.

30 Py,B., Higgins,C.F., Krisch,H.M. and Carpousis,A.J. (1996) Nature, 381, 169-172.

31 Nielsen,D.A. and Shapiro,D.J. (1990) Mol. Cell. Biol. 10, 371-376.

32 Shapiro,D.J., Barton,M.C., McKearin,D.M., Chang,T.-C., Lew,D., Blume,J., Nielsen,D.A. and Gould,L. (1989) Rec. Prog. Hormone Res. 45, 29-64.

33 Dodson,R.E. and Shapiro,D.J. (1994) Mol. Cell. Biol. 14, 3130-3138.


Return

*To whom correspondence should be addressed. Tel: +1 614 688 3012; Fax: +1 614 688 3012; Email: schoenberg.3@osu.edu

+ Present address: Abbott Diagnostics, PO Box 278, Barceloneta 00617, Puerto Rico
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
I. Ehlers, S. Horke, K. Reumann, A. Rang, F. Grosse, H. Will, and T. Heise
Functional Characterization of the Interaction between Human La and Hepatitis B Virus RNA
J. Biol. Chem., October 15, 2004; 279(42): 43437 - 43447.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
K. A. BREMER, A. STEVENS, and D. R. SCHOENBERG
An endonuclease activity similar to Xenopus PMR1 catalyzes the degradation of normal and nonsense-containing human {beta}-globin mRNA in erythroid cells
RNA, September 1, 2003; 9(9): 1157 - 1167.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
D. C. Mitchell and N. H. Ing
Estradiol Stabilizes Estrogen Receptor Messenger Ribonucleic Acid in Sheep Endometrium via Discrete Sequence Elements in Its 3'-Untranslated Region
Mol. Endocrinol., April 1, 2003; 17(4): 562 - 574.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Stevens, Y. Wang, K. Bremer, J. Zhang, R. Hoepfner, M. Antoniou, D. R. Schoenberg, and L. E. Maquat
beta -Globin mRNA decay in erythroid cells: UG site-preferred endonucleolytic cleavage that is augmented by a premature termination codon
PNAS, October 1, 2002; 99(20): 12741 - 12746.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
E. L. van Dijk, J. S. Sussenbach, and P. E. Holthuizen
Kinetics and regulation of site-specific endonucleolytic cleavage of human IGF-II mRNAs
Nucleic Acids Res., September 1, 2001; 29(17): 3477 - 3486.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Heise, L. G. Guidotti, and F. V. Chisari
Characterization of Nuclear RNases That Cleave Hepatitis B Virus RNA near the La Protein Binding Site
J. Virol., August 1, 2001; 75(15): 6874 - 6883.
[Abstract] [Full Text]


Home page
Nucleic Acids ResHome page
K. S. Cunningham, M. N. Hanson, and D. R. Schoenberg
Polysomal ribonuclease 1 exists in a latent form on polysomes prior to estrogen activation of mRNA decay
Nucleic Acids Res., March 1, 2001; 29(5): 1156 - 1162.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
W. Tirasophon, K. Lee, B. Callaghan, A. Welihinda, and R. J. Kaufman
The endoribonuclease activity of mammalian IRE1 autoregulates its mRNA and is required for the unfolded protein response
Genes & Dev., November 1, 2000; 14(21): 2725 - 2736.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. S. Cunningham, R. E. Dodson, M. A. Nagel, D. J. Shapiro, and D. R. Schoenberg
Vigilin binding selectively inhibits cleavage of the vitellogenin mRNA 3'-untranslated region by the mRNA endonuclease polysomal ribonuclease 1
PNAS, October 23, 2000; (2000) 220425497.
[Abstract] [Full Text]


Home page
Nucleic Acids ResHome page
Z. Zhao, F.-C. Chang, and H. M. Furneaux
The identification of an endonuclease that cleaves within an HuR binding site in mRNA
Nucleic Acids Res., July 15, 2000; 28(14): 2695 - 2701.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X.-L. Li, J. A. Blackford, C. S. Judge, M. Liu, W. Xiao, D. V. Kalvakolanu, and B. A. Hassel
RNase-L-dependent Destabilization of Interferon-induced mRNAs. A ROLE FOR THE 2-5A SYSTEM IN ATTENUATION OF THE INTERFERON RESPONSE
J. Biol. Chem., March 17, 2000; 275(12): 8880 - 8888.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. H. Lee, P. Leeds, and J. Ross
Purification and Characterization of a Polysome-associated Endoribonuclease That Degrades c-myc mRNA in Vitro
J. Biol. Chem., September 25, 1998; 273(39): 25261 - 25271.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. N. Hanson and D. R. Schoenberg
Identification of in Vivo mRNA Decay Intermediates Corresponding to Sites of in Vitro Cleavage by Polysomal Ribonuclease 1
J. Biol. Chem., April 6, 2001; 276(15): 12331 - 12337.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. S. Cunningham, R. E. Dodson, M. A. Nagel, D. J. Shapiro, and D. R. Schoenberg
Vigilin binding selectively inhibits cleavage of the vitellogenin mRNA 3'-untranslated region by the mRNA endonuclease polysomal ribonuclease 1
PNAS, November 7, 2000; 97(23): 12498 - 12502.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Print PDF (209K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (26)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Chernokalskaya, E.
Right arrow Articles by Schoenberg, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chernokalskaya, E.
Right arrow Articles by Schoenberg, D. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?